Your browser doesn't support javascript.
loading
Incidence of Malignancies Among Patients With Chronic Hepatitis B in US Health Care Organizations, 2006-2018.
Spradling, Philip R; Xing, Jian; Zhong, Yuna; Rupp, Loralee B; Moorman, Anne C; Lu, Mei; Teshale, Eyasu H; Schmidt, Mark A; Daida, Yihe G; Boscarino, Joseph A; Gordon, Stuart C.
Afiliação
  • Spradling PR; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Xing J; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Zhong Y; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Rupp LB; Henry Ford Health System, Detroit, Michigan, USA.
  • Moorman AC; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Lu M; Henry Ford Health System, Detroit, Michigan, USA.
  • Teshale EH; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Schmidt MA; The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Daida YG; The Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, Hawaii, USA.
  • Boscarino JA; Department of Population Health Sciences, Geisinger Clinic, Danville, Pennsylvania, USA.
  • Gordon SC; Henry Ford Health System, Detroit, Michigan, USA.
J Infect Dis ; 226(5): 896-900, 2022 09 13.
Article em En | MEDLINE | ID: mdl-35039863
ABSTRACT
Hepatitis B virus (HBV) infection causes hepatocellular carcinoma but its association with other cancers is not well established. We compared age-adjusted incidence of primary cancers among 5773 HBV-infected persons with US cancer registries during 2006-2018. Compared with the US population, substantially higher incidence among HBV-infected persons was observed for hepatocellular carcinoma (standardized rate ratio [SRR], 30.79), gastric (SRR, 7.95), neuroendocrine (SRR, 5.88), cholangiocarcinoma (SRR, 4.62), and ovarian (SRR, 3.72) cancers, and non-Hodgkin lymphoma (SRR, 2.52). Clinicians should be aware of a heightened potential for certain nonhepatic malignancies among hepatitis B patients, as earlier diagnosis favors improved survival.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Hepatite B / Neoplasias Hepáticas Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Hepatite B / Neoplasias Hepáticas Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos